The effect of lower LDL‐C on the risk of CHD mediated by polymorphisms in NPC1L1, HMGCR, or both is approximately the same per unit lower LDL‐C and log‐linearly proportional to the absolute exposure to lower LDL‐C. The gene discussed is NPC1L1; the disease is coronary artery disorder.